Sublicense Reports Sample Clauses

Sublicense Reports. Within forty-five (45) days of the last day of each quarter, VAR shall send Forte a report detailing for the quarter:
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Sublicense Reports. Ohr shall require each sublicensee to make appropriate reports to Ohr to enable Angion to comply with this Article 4. Ohr shall endeavor to require each sublicensee to provide to Ohr its respective reports in a timely manner so as to enable Ohr to include such sublicensee’s report in Ohr’s report for the quarter that is the subject of the sublicensee’s report.
Sample 1Sample 2
Sublicense Reports. With each order for Programs for Sublicense to a Sublicensee, the Alliance Member shall send Oracle a report detailing for each Sublicensed Full Use Program: Sublicensee name, address, make/model and operating system of the Designated System, Full Use Programs, maximum number of licensed Users, whether the Sublicense is a Trial Sublicense, total Program fees and Technical Support Fees due to Oracle and specific descriptions of the Integrated System and Value-Added.
Sample 1
Sublicense Reports. Within thirty (30) days of the last day of each calendar quarter, AP shall send BOA a report detailing for that calendar quarter for each sublicensee: (a) such Sublicensee's name and address, (b) the platform, (c) the date of sale, (d) the number of users and (e) the total Sublicense License Fees and Sublicense Support Fees due BOA (the "Sublicense Report"). 5.9
Sample 1
Sublicense Reports. Within thirty (30) days of the last day of each ------------------ quarter, VAR shall send BOI, if requested by BOI, (a) a report detailing for that quarter for each sublicensee (i) such sublicensee's name and address, (ii) the platform, (iii) the date of installation, (iv) the number of users and (v) the total Sublicense License Fees and Sublicense Support Fees due BOI (the "Sublicense Report"); and (b) a copy of the Sublicense License Agreement signed and dated by VAR and each such sublicensee.
Sample 1
Sublicense Reports. Within twenty (20) days of the last day of each and every calendar quarter, Emony shall send to BackWeb a report detailing for that quarter each Sublicensed Application Program shipped or licensed during that month, number of Users, total Royalties related to such Application Programs, and total Sublicense fees and Technical Support Fees due to BackWeb. Emony shall pay to BackWeb any Sublicense fees and Technical Support fees upon Emony's receipt of an invoice from BackWeb.
Sample 1
Sublicense Reports. Within twenty (20) days of the last day of each and every month, the Alliance Member shall send Oracle a report detailing for that month:
Sample 1
AutoNDA by SimpleDocs
Sublicense Reports. The quarterly Sublicense report is to contain the following information: number of sublicenses distributed during the preceding quarter; sub-licensees to which licenses were granted including: company name, physical address, phone, fax, contact person, and quantity of licenses; description of products including Source Code, Linkable Object, and Executable code; license fees paid by each Sublicensee; number of Sub-licensee’s that ordered Technical Support; calculation of fees due to MTI. Sublicense reports and payments shall be sent to Mapusoft Technologies Inc., Accounts Receivable, 0000 Xxxxxx Xxxx, Xxxxxx, XX 00000. Licensee shall also provide MTI copies of the applicable signed license agreement for each Sublicensee.
Sample 1
Sublicense Reports 
Sample 1

Related to Sublicense Reports

  • Royalty Reports After the first commercial sale of a Licensed Product anywhere in the world, LICENSEE shall submit to UNIVERSITY quarterly royalty reports on or before each February 28, May 31, August 31 and November 30 of each year. Each royalty report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar quarter and shall show:

  • Sublicense Requirements Any Sublicense:

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Sublicense Revenue In the event Licensee or an Affiliate of Licensee sublicenses under Section 2.2, Licensee shall pay CareFusion **THE CONFIDENTIAL PORTION HAS BEEN SO OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION.** of any Sublicense Revenues resulting from sublicense agreements executed by Licensee.

  • Royalty Report The term “Royalty Report” shall have the meaning ascribed to such term as provided in Section 5.4.

  • Research Reports Distributor acknowledges that Dealer may prepare research reports relating to the Fund that are not to be used for marketing purposes (“Research Reports”). Distributor hereby authorizes Dealer to use the name of the Fund, Distributor and BREDS in Research Reports.

  • PROGRESS AND ROYALTY REPORTS 8.1 For the period beginning [date] LICENSEE will submit to REGENTS a semi-annual progress report covering LICENSEE's activities related to the development and testing of all LICENSED PRODUCTS, LICENSED SERVICES and LICENSED METHOD and the obtaining of necessary governmental approvals, if any, for marketing in the United States. These progress reports will be made for all development activities until the first SALE occurs in the United States.

  • Development Reports Beginning six months after Effective Date and ending on the date of first commercial sale of a Licensed Product in the United States, LICENSEE shall report to Cornell progress covering LICENSEE's (and Affiliate's and Sublicensee's) activities and efforts in the development of rights granted to LICENSEE under this Agreement for the preceding six months. The report shall include, but not be limited to, activities and efforts to develop and test all Licensed Products and obtain governmental approvals necessary for marketing the same. Such semi-annual reports shall be due within sixty days (60) of the reporting period and shall use the form as provided herein as Appendix C.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

Time is Money Join Law Insider Premium to draft better contracts faster.